Pentagon Hands Out $84.4 Million in Small Contracts

The Department of Defense announced a series of small (in defense contracting terms) contract awards to a series of publicly traded companies Thursday. Among them:

  • United Technologies (NYSE: UTX  ) subsidiary Sikorsky won the largest award, a $26.9 million firm-fixed-price foreign military sales contract to convert an unspecified number of UH-60M Black Hawk helicopters for use by the Royal Thailand Army. This contract should be completed by April 30, 2016.
  • In other helicopter news, Boeing (NYSE: BA  ) won a $17.9 million cost-plus-fixed-fee contract to perform design and engineering work on the CH-47 Advanced Chinook Rotor Blade. This contract funds work through March 18, 2017.
  • One contract that sounds like it involves helicopters -- but doesn't -- is the $7.6 million DARPA contract that UTC subsidiary Goodrich just won. In this cost-plus-fixed-fee award, Goodrich will work on Phase 3 of the "Hybrid Multi-Material Rotor (HMMR) program" -- a DARPA project to develop new hi-performance rotors for submarine screws. Goodrich's expected completion date on this work is Sept. 30, 2014.
  • Raytheon (NYSE: RTN  ) was awarded $8.8 million in a firm-fixed-price contract to replace obsolete Pulse Code Modulation (PCM) Encoders in Tomahawk missiles. The PCM Encoder samples flight test missile guidance and avionics telemetry data stream, encodes and formats the data, and provides telemetry information to ground monitoring stations. Raytheon should complete work on this task by March 2015.
  • In the day's smallest award, International Business Machines (NYSE: IBM  ) won an $8.1 million firm-fixed-price, incrementally-funded contract to support of the Army Learning Management System through March 21, 2014.
  • And finally, Sanofi (NYSE: SNY  ) subsidiary Sanofi Pasteur VaxDesign Corporation was awarded $15.1 million to perform research and development work on an in vitro biomimetic immune system for the Defense Threat Reduction Agency (DTRA). The objective here is to find better ways to test immune responses to difference agents in the lab, to facilitate development of vaccines and immunotherapeutics. Completion date on the work: March 24, 2017.
 

Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

DocumentId: 2326613, ~/Articles/ArticleHandler.aspx, 7/31/2014 5:45:26 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated Moments ago Sponsored by:
DOW 16,563.30 -317.06 -1.88%
S&P 500 1,930.67 -39.40 -2.00%
NASD 4,369.77 -93.13 -2.09%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

7/31/2014 4:02 PM
BA $120.48 Down -1.81 -1.48%
The Boeing Company CAPS Rating: ***
IBM $191.67 Down -2.33 -1.20%
International Busi… CAPS Rating: ****
RTN $90.77 Down -1.85 -2.00%
Raytheon Company CAPS Rating: ****
SNY $52.27 Up +0.09 +0.17%
Sanofi (ADR) CAPS Rating: *****
UTX $105.15 Down -1.23 -1.16%
United Technologie… CAPS Rating: ****

Advertisement